Taus

CSOFT’s CEO Shunee Yee at TAUS 2019: Past, Present, & Future of Translation & Localization

October 16-18, Singapore, TAUS 2019, Mandarin Orchard Hotel Deep in the heart of the historic Mandarin Orchard Hotel in Singapore, leaders of localization and translation companies met to discuss nothing less than the very future of the industry. Unbeknownst to guests and travelers, the hotel’s conference room hosts TAUS 2019, an event where industry giants […]

Empire Boston – Thank You for Attending our Event!

Thank you to all for making Tuesday a special evening! CSOFT’s sponsored V.I.P. Social at the elegant Empire Restaurant Boston was a large success. We welcomed guests from around the world within the medical industry. The evening’s cuisine was paired with smooth Jazz and great conversation. All of it was made possible by our wonderful […]

MedTech

2019 MedTech Conference in Boston

On September 23-25th, CSOFT will be attending the Medtech Conference in Boston along with 3,000 other attendees to network and share insight with medical technology industry leaders. Attendees will have the opportunity to witness more than 300 speakers discuss topics pertinent to today’s medical technology industry such as the increasing use of artificial intelligence, regulations […]

CSOFT

Translating China: Succeeding in China’s Translation Industry

At 11:00 EDT on July 18, 2018 Joshua Hughman, Director of Business Development, Europe, who was previously the Director of  Business development for our Global Communications department based in China at CSOFT International will be presenting a Webinar partnered with GALA (Globalization and Localization Association) about how he has found success in the Chinese translation […]

FDA Approves The First Generic Inhaler of Advair Diskus

On January 30, 2019, the FDA approved the first generic version of Advair Diskus. This popular inhaler medication is one of the most commonly used prescriptions for treating Asthma and Chronic Obstruction Pulmonary Disease (COPD). This new license will provide patients with access to more affordable prescriptions. This advancement will also affect the drug market in other parts of the world.